FI77850C - Foerfarande foer framstaellning av 4-bensyloxi- eller 4-naftylmetoxipiperidinderivat, vilka har antidepressiv verkan. - Google Patents
Foerfarande foer framstaellning av 4-bensyloxi- eller 4-naftylmetoxipiperidinderivat, vilka har antidepressiv verkan. Download PDFInfo
- Publication number
- FI77850C FI77850C FI813330A FI813330A FI77850C FI 77850 C FI77850 C FI 77850C FI 813330 A FI813330 A FI 813330A FI 813330 A FI813330 A FI 813330A FI 77850 C FI77850 C FI 77850C
- Authority
- FI
- Finland
- Prior art keywords
- group
- alkyl
- formula
- compound
- radical
- Prior art date
Links
- 230000001430 anti-depressive effect Effects 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title claims description 7
- VFFRRBDDVSRZCV-UHFFFAOYSA-N 4-(naphthalen-1-ylmethoxy)piperidine Chemical class C=1C=CC2=CC=CC=C2C=1COC1CCNCC1 VFFRRBDDVSRZCV-UHFFFAOYSA-N 0.000 title claims description 4
- 238000000034 method Methods 0.000 title claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 15
- 150000003254 radicals Chemical class 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- -1 methylenedioxy group Chemical group 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 6
- 239000000935 antidepressant agent Substances 0.000 claims description 5
- 229940005513 antidepressants Drugs 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- LEVJVKGPFAQPOI-UHFFFAOYSA-N phenylmethanone Chemical group O=[C]C1=CC=CC=C1 LEVJVKGPFAQPOI-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 40
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 239000000047 product Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 15
- 238000003756 stirring Methods 0.000 description 13
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 125000001309 chloro group Chemical group Cl* 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 2
- GKGCPWOZAGTHMX-UHFFFAOYSA-N (4-hydroxypiperidin-1-yl)-(4-nitrophenyl)methanone Chemical compound C1CC(O)CCN1C(=O)C1=CC=C([N+]([O-])=O)C=C1 GKGCPWOZAGTHMX-UHFFFAOYSA-N 0.000 description 2
- DZQJPPKZMLZEDA-UHFFFAOYSA-N (4-nitrophenyl)-[4-[(3,4,5-trimethoxyphenyl)methoxy]piperidin-1-yl]methanone Chemical compound COC1=C(OC)C(OC)=CC(COC2CCN(CC2)C(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 DZQJPPKZMLZEDA-UHFFFAOYSA-N 0.000 description 2
- AFQWTJFPNZJKGL-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-4-[(3,4,5-trimethoxyphenyl)methoxy]piperidine Chemical compound COC1=C(OC)C(OC)=CC(COC2CCN(CC=3C=CC(Cl)=CC=3)CC2)=C1 AFQWTJFPNZJKGL-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- UWOVDQAMRNZVIM-UHFFFAOYSA-N 4-[(3,4,5-trimethoxyphenyl)methoxy]piperidine Chemical compound COC1=C(OC)C(OC)=CC(COC2CCNCC2)=C1 UWOVDQAMRNZVIM-UHFFFAOYSA-N 0.000 description 2
- HKWRVHLLZSIWAR-UHFFFAOYSA-N 4-[(4-fluorophenyl)methoxy]piperidine Chemical compound C1=CC(F)=CC=C1COC1CCNCC1 HKWRVHLLZSIWAR-UHFFFAOYSA-N 0.000 description 2
- XXRUQNNAKXZSOS-UHFFFAOYSA-N 5-(chloromethyl)-1,2,3-trimethoxybenzene Chemical compound COC1=CC(CCl)=CC(OC)=C1OC XXRUQNNAKXZSOS-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- WGIFUQXAAHCOJU-UHFFFAOYSA-N [4-[(4-fluorophenyl)methoxy]piperidin-1-yl]-(4-nitrophenyl)methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)N1CCC(OCC=2C=CC(F)=CC=2)CC1 WGIFUQXAAHCOJU-UHFFFAOYSA-N 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 229960002510 mandelic acid Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 2
- 229960003147 reserpine Drugs 0.000 description 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 2
- VEXLZSWFSWYAON-UHFFFAOYSA-N (4-chlorophenyl)-(4-hydroxypiperidin-1-yl)methanone Chemical compound C1CC(O)CCN1C(=O)C1=CC=C(Cl)C=C1 VEXLZSWFSWYAON-UHFFFAOYSA-N 0.000 description 1
- UNOWCXQLPMFMSW-UHFFFAOYSA-N (4-chlorophenyl)-[4-[(3,4,5-trimethoxyphenyl)methoxy]piperidin-1-yl]methanone Chemical compound COC1=C(OC)C(OC)=CC(COC2CCN(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 UNOWCXQLPMFMSW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-ZETCQYMHSA-M (S)-mandelate Chemical compound [O-]C(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-M 0.000 description 1
- BPPZXJZYCOETDA-UHFFFAOYSA-N 1-benzylpiperidin-4-ol Chemical compound C1CC(O)CCN1CC1=CC=CC=C1 BPPZXJZYCOETDA-UHFFFAOYSA-N 0.000 description 1
- JQZAEUFPPSRDOP-UHFFFAOYSA-N 1-chloro-4-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1 JQZAEUFPPSRDOP-UHFFFAOYSA-N 0.000 description 1
- BAUWRHPMUVYFOD-UHFFFAOYSA-N 1-methylpiperidin-4-ol Chemical compound CN1CCC(O)CC1 BAUWRHPMUVYFOD-UHFFFAOYSA-N 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- OVUJZMQPHDVQLL-UHFFFAOYSA-N 4-[(4-chlorophenyl)methoxy]-1-methylpiperidine Chemical compound C1CN(C)CCC1OCC1=CC=C(Cl)C=C1 OVUJZMQPHDVQLL-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- ILJHWVWEYBJDDM-UHFFFAOYSA-N 4-phenylmethoxypiperidine Chemical compound C=1C=CC=CC=1COC1CCNCC1 ILJHWVWEYBJDDM-UHFFFAOYSA-N 0.000 description 1
- TYZNPXDFDHBMNU-UHFFFAOYSA-N 4-phenylmethoxypiperidine;hydrochloride Chemical compound Cl.C=1C=CC=CC=1COC1CCNCC1 TYZNPXDFDHBMNU-UHFFFAOYSA-N 0.000 description 1
- AEYGNIKQMYCBQT-UHFFFAOYSA-N COC=1C=C(CON2CCCCC2)C=C(C=1OC)OC Chemical compound COC=1C=C(CON2CCCCC2)C=C(C=1OC)OC AEYGNIKQMYCBQT-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 125000005055 alkyl alkoxy group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- XPWFJLQMBNOIFW-UHFFFAOYSA-N ethyl 4-phenylmethoxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1OCC1=CC=CC=C1 XPWFJLQMBNOIFW-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229960002888 oxitriptan Drugs 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK469381A DK157853C (da) | 1981-10-23 | 1981-10-23 | Analogifremgangsmaade til fremstilling af 4-benzyloxypiperidinderivater |
| FI813330A FI77850C (fi) | 1981-10-23 | 1981-10-23 | Foerfarande foer framstaellning av 4-bensyloxi- eller 4-naftylmetoxipiperidinderivat, vilka har antidepressiv verkan. |
| ES506500A ES506500A0 (es) | 1981-10-23 | 1981-10-23 | Procedimiento de preparacion de derivados de piperidina |
| IE2500/81A IE51707B1 (en) | 1981-10-23 | 1981-10-23 | Piperidine derivatives,their preparation and pharmaceutical compositions containing them |
| ZA817373A ZA817373B (en) | 1981-10-23 | 1981-10-23 | Piperidine derivatives,their preparation and pharmaceutical compositions containing them |
| NZ198748A NZ198748A (en) | 1981-10-23 | 1981-10-23 | Piperidine derivatives and pharmaceutical compositions |
| NO813577A NO153890C (no) | 1981-10-23 | 1981-10-23 | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. |
| AU76769/81A AU545739B2 (en) | 1981-10-23 | 1981-10-23 | Piperidine derivatives |
| JP56170536A JPS5872565A (ja) | 1981-10-23 | 1981-10-23 | ピペリジン誘導体およびその製造方法 |
| CA000388595A CA1173039A (en) | 1981-10-23 | 1981-10-23 | 4-benzyloxypiperidine compounds |
| GR66337A GR75364B (enrdf_load_stackoverflow) | 1981-10-23 | 1981-10-23 | |
| PT73875A PT73875B (fr) | 1981-10-23 | 1981-10-23 | Procede de preparation de derives de piperidine applicables en therapeutique |
Applications Claiming Priority (24)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU7676981 | 1981-10-23 | ||
| CA388595 | 1981-10-23 | ||
| DK469381A DK157853C (da) | 1981-10-23 | 1981-10-23 | Analogifremgangsmaade til fremstilling af 4-benzyloxypiperidinderivater |
| ES506500 | 1981-10-23 | ||
| FI813330A FI77850C (fi) | 1981-10-23 | 1981-10-23 | Foerfarande foer framstaellning av 4-bensyloxi- eller 4-naftylmetoxipiperidinderivat, vilka har antidepressiv verkan. |
| ES506500A ES506500A0 (es) | 1981-10-23 | 1981-10-23 | Procedimiento de preparacion de derivados de piperidina |
| IE2500/81A IE51707B1 (en) | 1981-10-23 | 1981-10-23 | Piperidine derivatives,their preparation and pharmaceutical compositions containing them |
| JP17053681 | 1981-10-23 | ||
| ZA817373A ZA817373B (en) | 1981-10-23 | 1981-10-23 | Piperidine derivatives,their preparation and pharmaceutical compositions containing them |
| NZ198748A NZ198748A (en) | 1981-10-23 | 1981-10-23 | Piperidine derivatives and pharmaceutical compositions |
| DK469381 | 1981-10-23 | ||
| NO813577A NO153890C (no) | 1981-10-23 | 1981-10-23 | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. |
| AU76769/81A AU545739B2 (en) | 1981-10-23 | 1981-10-23 | Piperidine derivatives |
| JP56170536A JPS5872565A (ja) | 1981-10-23 | 1981-10-23 | ピペリジン誘導体およびその製造方法 |
| PT7387581 | 1981-10-23 | ||
| ZA8107373 | 1981-10-23 | ||
| NZ19874881 | 1981-10-23 | ||
| CA000388595A CA1173039A (en) | 1981-10-23 | 1981-10-23 | 4-benzyloxypiperidine compounds |
| GR810166337 | 1981-10-23 | ||
| GR66337A GR75364B (enrdf_load_stackoverflow) | 1981-10-23 | 1981-10-23 | |
| IE250081 | 1981-10-23 | ||
| NO813577 | 1981-10-23 | ||
| FI813330 | 1981-10-23 | ||
| PT73875A PT73875B (fr) | 1981-10-23 | 1981-10-23 | Procede de preparation de derives de piperidine applicables en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI813330L FI813330L (fi) | 1983-04-24 |
| FI77850B FI77850B (fi) | 1989-01-31 |
| FI77850C true FI77850C (fi) | 1989-05-10 |
Family
ID=27582840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI813330A FI77850C (fi) | 1981-10-23 | 1981-10-23 | Foerfarande foer framstaellning av 4-bensyloxi- eller 4-naftylmetoxipiperidinderivat, vilka har antidepressiv verkan. |
Country Status (12)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02148948U (enrdf_load_stackoverflow) * | 1989-05-17 | 1990-12-18 | ||
| US5169855A (en) * | 1990-03-28 | 1992-12-08 | Du Pont Merck Pharmaceutical Company | Piperidine ether derivatives as psychotropic drugs or plant fungicides |
| JPH0535676U (ja) * | 1991-06-06 | 1993-05-14 | 株式会社カネマス | 乾燥海草の水戻し用パツク |
-
1981
- 1981-10-23 GR GR66337A patent/GR75364B/el unknown
- 1981-10-23 CA CA000388595A patent/CA1173039A/en not_active Expired
- 1981-10-23 FI FI813330A patent/FI77850C/fi not_active IP Right Cessation
- 1981-10-23 AU AU76769/81A patent/AU545739B2/en not_active Ceased
- 1981-10-23 IE IE2500/81A patent/IE51707B1/en not_active IP Right Cessation
- 1981-10-23 ZA ZA817373A patent/ZA817373B/xx unknown
- 1981-10-23 ES ES506500A patent/ES506500A0/es active Granted
- 1981-10-23 DK DK469381A patent/DK157853C/da not_active IP Right Cessation
- 1981-10-23 PT PT73875A patent/PT73875B/pt unknown
- 1981-10-23 NO NO813577A patent/NO153890C/no unknown
- 1981-10-23 JP JP56170536A patent/JPS5872565A/ja active Granted
- 1981-10-23 NZ NZ198748A patent/NZ198748A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI77850B (fi) | 1989-01-31 |
| GR75364B (enrdf_load_stackoverflow) | 1984-07-13 |
| DK469381A (da) | 1983-04-24 |
| AU7676981A (en) | 1983-04-28 |
| NO153890B (no) | 1986-03-03 |
| ZA817373B (en) | 1983-03-30 |
| JPS5872565A (ja) | 1983-04-30 |
| NO153890C (no) | 1986-06-11 |
| PT73875B (fr) | 1983-01-25 |
| ES8206476A1 (es) | 1982-08-16 |
| PT73875A (fr) | 1981-11-01 |
| DK157853C (da) | 1990-08-06 |
| ES506500A0 (es) | 1982-08-16 |
| JPS6135177B2 (enrdf_load_stackoverflow) | 1986-08-12 |
| AU545739B2 (en) | 1985-08-01 |
| FI813330L (fi) | 1983-04-24 |
| IE51707B1 (en) | 1987-02-18 |
| NZ198748A (en) | 1984-08-24 |
| IE812500L (en) | 1983-04-21 |
| DK157853B (da) | 1990-02-26 |
| CA1173039A (en) | 1984-08-21 |
| NO813577L (no) | 1983-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK16288A (en) | Dihydropyridine anti-ischaemic and antihypertensive agents, processes for their production, and pharmaceutical compositions containing them | |
| PL131190B1 (en) | Process for preparing novel derivatives of dihydropyridine | |
| AU697552B2 (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments | |
| IE832058L (en) | 1,4-dihydropyridine derivatives | |
| FI67211B (fi) | Foerfarande foer framstaellning av nya saosom antiarrytmimedelanvaendbara 9-aminoalkylfluorener | |
| US4529730A (en) | Piperidine derivatives, their preparation and pharmaceutical compositions containing them | |
| FI77850C (fi) | Foerfarande foer framstaellning av 4-bensyloxi- eller 4-naftylmetoxipiperidinderivat, vilka har antidepressiv verkan. | |
| PL84346B1 (en) | 3-aroyl-alkenyleneimines[us3835149a] | |
| US20100016299A1 (en) | Substituted benzoxepino-isoxazoles and use thereof | |
| PT90127B (pt) | Processo para a preparacao de composicoes farmaceuticas com accao analgesica que contem 4-aril-4-piperidino (ou pirrolidino ou hexa-hidroazepino)-carbinois ou os seus analogos heterociclicos | |
| JPH0610192B2 (ja) | ビ―２ｈ―ピロール―ジオン化合物 | |
| IE46385B1 (en) | N-9, 10-dihydrolysergyl-m-aminobenzinc acid amides and related compounds | |
| HU194879B (en) | Process for producing 1,6-naphtiridine derivatives and pharmaceutical compositions containing them | |
| JPH0319236B2 (enrdf_load_stackoverflow) | ||
| CA1323876C (en) | Dihydropyridine derivatives and pharmaceutical composition thereof | |
| JPH03120271A (ja) | 抗虚血活性を有するフェニルアルキルアミン誘導体 | |
| US5618822A (en) | N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them | |
| US4438121A (en) | Isoquinoline amidoxime derivatives | |
| KR100355973B1 (ko) | 페닐-치환1,4-디히드로피리딘 | |
| FI63578B (fi) | Analogifoerfarande foer framstaellning av nya farmakologiskt verksamma 1,3,4,14b-tetrahydro-2h,10h-pyrazino(1,2-a)pyrrolo(2,1-c)(1,4)bensodiazepiner | |
| EP0553278B1 (en) | 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties | |
| FI60863C (fi) | Foerfarande foer framstaellning av nya bentshydryloxialkylaminderivat med foerlaengd antihistamineffekt | |
| FI83957C (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara diarylfoereningar. | |
| JP2000351766A (ja) | 新規１−アザ−２−アルキル−６−アリール−シクロアルカン化合物類、それらの製造方法及びそれらを含む医薬組成物 | |
| AU662730B2 (en) | Neuroprotectant agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: SYNTHELABO |